Business

Definitive Healthcare Announces Closing of Follow-On Offering of 11,000,000 Shares of Class A Common Stock

FRAMINGHAM, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare

articleDefinitive Healthcare Corp.November 22, 20213/company/definitive-healthcare-corp/news/definitive-healthcare-announces-closing-of-follow-on-offering-of-11000000-shares-of-class-a-common-stock
Definitive Healthcare Announces Closing of Follow-On Offering of 11,000,000 Shares of Class A Common Stock

About this update from Definitive Healthcare Corp.

[{"type":"text","content":"FRAMINGHAM, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the closing of its previously announced underwritten public offering of 11,000,000 shares of its Class A common stock at a price to the public of $36.00 per share. The underwriters have a 30-day option to purchase up to an additional 1,650,000 shares of its Class A common stock at the public offering price, less underwriting discounts and commissions. Definitive Healthcare intends to use the net proceeds from the offering (a) for acquisitions and general corporate purposes, including purchasing 7,000,000 newly issued limited liability interests from its subsidiary AIDH TopCo, LLC, and (b) to repurchase an aggregate of 2,233,238 shares of Class A common stock and purchase 1,766,762 limited liability interests in AIDH TopCo, LLC from existing holders in a “synthetic secondary” transaction. In the event the underwriters exercise their option to purchase additional shares, Definitive Healthcare will use the net proceeds to repurchase additional shares of Class A common stock and purchase limited liability interests in AIDH TopCo, LLC from existing holders. Goldman Sachs & Co. LLC and J.P. Morgan acted as lead joint book-running managers and representatives of the underwriters for the offering. Morgan Stanley & Co. LLC and Barclays Capital Inc. acted as joint book-running managers and are also representatives of the underwriters for the offering. Credit Suisse Securities (USA) LLC and Deutsche Bank Securities Inc. acted as book-runners for the offering. Canaccord Genuity LLC, Raymond James & Associates, Inc., Stifel, Nicolaus & Company, Incorporated, Drexel Hamilton, LLC and Loop Capital Markets acted as co-managers. The offering was made only by means of a prospectus. A copy of the final prospectus relating to the offering may be obtained from the Securities and Exchange Commission (“SEC”) at www.sec.gov or from: Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526 or by email at [email protected]; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (866) 803-9204 or by email at prospectuse...

More updates from Definitive Healthcare Corp.